Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety and pharmacokinetic study of sublingual melatonin in healthy adult men
RBR-8hc3zfPhase 1Not yet recruiting
- Sponsor
- Instituto de Ciências Farmacêuticas
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of melatonin in Insomnia (5 arms), sponsored by Instituto de Ciências Farmacêuticas. Primary endpoints: Safety and Pharmacokinetics. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on RBR-8hc3zf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8hc3zf.